Active

GRAMPIAN BIOPARTNERS LIMITED Financials

Company number
SC339134Copy
copy info iconCopy
Registered office
18 Abbotshall Drive, Cults, Aberdeen, Scotland AB15 9JD
Incorporated
07/03/2008

Company snapshot

Status
Active
Employees
3 (2026)
Latest financial data
2026
Accounts type
Total Exemption Full

Financial highlights

Latest reported figures. Okredo holds filed data for 2022–2026.

Net Assets

£-93.82K2026
-1.33%vs 2025

2025: £-92.58K

Total Assets

£2.27K2026
-41.63%vs 2025

2025: £3.89K

Cash in Bank

£770.002026
-67.77%vs 2025

2025: £2.39K

Total Liabilities

£96.09K2026
-0.40%vs 2025

2025: £96.47K

Employees

32026
0vs 2025

2025: 3

In 2026, GRAMPIAN BIOPARTNERS LIMITED reported net assets of £-93.82K. The same filing shows total assets of £2.27K, cash in bank of £770.00 and total liabilities of £96.09K. Reported headcount was 3 in 2026. Total Assets fell from £3.89K in 2025 to £2.27K in 2026 (-41.63%). Okredo holds filed figures for 2022–2026; the table below lists every reported indicator by year. See every reported indicator by year.

Financial performance

Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.

Net Assets

£-93.82K2026
-1.33%from £-92.58K in 2025

Year-on-year change

Net Assets as filed for 2022–2026. Every figure in this chart is also in the financial history table.

3-year financial trend (2024–2026)

How the figures GRAMPIAN BIOPARTNERS LIMITED filed moved across the three reported years 2024, 2025 and 2026 — measured end to end rather than year on year.

Net Assets

£-90.82K2024£-93.82K2026
Decreasedvs 2024

Cash in Bank

£4.01K2024£770.002026
-80.8%vs 2024

-56.2% a year compound (CAGR)

Total Assets

£5.51K2024£2.27K2026
-58.8%vs 2024

-35.8% a year compound (CAGR)

Total Liabilities

£96.63K2024£96.09K2026
-0.6%vs 2024

-0.3% a year compound (CAGR)

Employees

3202432026
0%vs 2024

Biggest decrease

Cash in Bank-80.8%

£4.01K in 2024 to £770.00 in 2026

Every measure that changed in GRAMPIAN BIOPARTNERS LIMITED's filings between 2024 and 2026 fell. The steepest fall came in cash in bank, pointing to a tighter cash position, with net assets, total assets and total liabilities falling alongside it. See the full year-by-year figures.

Ratios from the filed figures

Calculated from GRAMPIAN BIOPARTNERS LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.

Net assets to total assets
-4,133.00%2026

Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.

Liabilities to total assets
4,233.00%2026

Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.

Cash to liabilities
0.80%2026

Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.

Cash to total assets
33.92%2026

Reported cash in bank divided by reported total assets, for the latest year both were filed.

Financial history

Every indicator Okredo tracks, year by year.

Reported financial indicators for GRAMPIAN BIOPARTNERS LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.

Indicator20222023202420252026
Net Assets£-85.51K89.13K-90.82K-92.58K-93.82K
Total Assets£10.63K–5.51K3.89K2.27K
Cash in Bank£8.92K5.88K4.01K2.39K770.00
Total Liabilities£97.04K–96.63K96.47K96.09K
Employees33333

GRAMPIAN BIOPARTNERS LIMITED financials: frequently asked questions

Answered from this company's own filed figures.

Has GRAMPIAN BIOPARTNERS LIMITED filed financial statements?

toggle

Yes. Okredo holds filed figures for GRAMPIAN BIOPARTNERS LIMITED covering 2022–2026, across 5 reported indicators. The most recent reported year is 2026.

What net assets did GRAMPIAN BIOPARTNERS LIMITED report in 2026?

toggle

GRAMPIAN BIOPARTNERS LIMITED reported net assets of £-93.82K for 2026. That compares with £-92.58K in 2025, a change of -1.33%.

What total assets did GRAMPIAN BIOPARTNERS LIMITED report in 2026?

toggle

GRAMPIAN BIOPARTNERS LIMITED reported total assets of £2.27K for 2026. That compares with £3.89K in 2025, a change of -41.63%.

What cash in bank did GRAMPIAN BIOPARTNERS LIMITED report in 2026?

toggle

GRAMPIAN BIOPARTNERS LIMITED reported cash in bank of £770.00 for 2026. That compares with £2.39K in 2025, a change of -67.77%.

How many people does GRAMPIAN BIOPARTNERS LIMITED employ?

toggle

GRAMPIAN BIOPARTNERS LIMITED reported 3 employees in 2026, compared with 3 in 2025.

How have GRAMPIAN BIOPARTNERS LIMITED financials changed over the last 3 years?

toggle

Between 2024 and 2026, GRAMPIAN BIOPARTNERS LIMITED's cash in bank fell by 80.8%, total assets fell by 58.8%, total liabilities fell by 0.6% and employee numbers was unchanged. Cash in bank contracted at 56.2% a year across the two years to 2026, from £4.01K to £770.00. Reported headcount went from 3 in 2024 to 3 in 2026.

Which years of GRAMPIAN BIOPARTNERS LIMITED financial data are available?

toggle

Okredo holds reported figures for the years 2022, 2023, 2024, 2025, 2026. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.